全文获取类型
收费全文 | 3642篇 |
免费 | 125篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 36篇 |
妇产科学 | 14篇 |
基础医学 | 560篇 |
口腔科学 | 88篇 |
临床医学 | 213篇 |
内科学 | 1008篇 |
皮肤病学 | 20篇 |
神经病学 | 298篇 |
特种医学 | 123篇 |
外科学 | 704篇 |
综合类 | 7篇 |
预防医学 | 77篇 |
眼科学 | 21篇 |
药学 | 161篇 |
中国医学 | 8篇 |
肿瘤学 | 421篇 |
出版年
2023年 | 11篇 |
2022年 | 32篇 |
2021年 | 36篇 |
2020年 | 22篇 |
2019年 | 38篇 |
2018年 | 41篇 |
2017年 | 37篇 |
2016年 | 46篇 |
2015年 | 62篇 |
2014年 | 83篇 |
2013年 | 99篇 |
2012年 | 170篇 |
2011年 | 168篇 |
2010年 | 107篇 |
2009年 | 98篇 |
2008年 | 249篇 |
2007年 | 260篇 |
2006年 | 254篇 |
2005年 | 303篇 |
2004年 | 250篇 |
2003年 | 277篇 |
2002年 | 254篇 |
2001年 | 39篇 |
2000年 | 45篇 |
1999年 | 57篇 |
1998年 | 87篇 |
1997年 | 58篇 |
1996年 | 56篇 |
1995年 | 51篇 |
1994年 | 62篇 |
1993年 | 56篇 |
1992年 | 51篇 |
1991年 | 43篇 |
1990年 | 40篇 |
1989年 | 34篇 |
1988年 | 22篇 |
1987年 | 10篇 |
1986年 | 8篇 |
1985年 | 8篇 |
1984年 | 14篇 |
1983年 | 14篇 |
1982年 | 12篇 |
1981年 | 15篇 |
1980年 | 25篇 |
1979年 | 6篇 |
1978年 | 9篇 |
1977年 | 14篇 |
1976年 | 5篇 |
1968年 | 6篇 |
1931年 | 4篇 |
排序方式: 共有3788条查询结果,搜索用时 15 毫秒
51.
52.
53.
A variety of contractile agonists trigger activation of the small GTPase RhoA. An important target of activated RhoA in smooth
muscle is Rho-associated kinase (ROK), one of the downstream targets that is the myosin binding subunit (MYPT1) of myosin
light chain phosphatase (MLCP). Phosphorylation of MYPT1 at T695 by activated ROK results in a decrease in phosphatase activity
of MLCP and an increase in myosin light chain (LC20) phosphorylation catalyzed by Ca2+/calmodulin-dependent myosin light chain kinase and/or a distinct Ca2+-independent kinase. LC20 phosphorylation in turn triggers cross-bridge cycling and force development. ROK also phosphorylates
the cytosolic protein CPI-17 (at T38), which thereby becomes a potent inhibitor of MLCP. The RhoA/ROK pathway has been implicated
in the tonic phase of force maintenance in response to various agonists, with no evident role in the phasic response, suggesting
this pathway as a potential target for antihypertensive therapy. Indeed, ROK inhibitors restore normal blood pressure in several
rat hypertensive models. 相似文献
54.
Metabolism of (‐)‐cis‐ and (‐)‐trans‐rose oxide by cytochrome P450 enzymes in human liver microsomes 下载免费PDF全文
Hiroshi Nakahashi Yuuki Yamamura Atsushi Usami Pramoch Rangsunvigit Pomthong Malakul Mitsuo Miyazawa 《Biopharmaceutics & drug disposition》2015,36(9):565-574
The in vitro metabolism of (‐)‐cis‐ and (‐)‐trans‐rose oxide was investigated using human liver microsomes and recombinant cytochrome P450 (P450 or CYP) enzymes for the first time. Both isomers of rose oxide were incubated with human liver microsomes, and the formation of the respective 9‐oxidized metabolite were determined using gas chromatography‐mass spectrometry (GC‐MS). Of 11 different recombinant human P450 enzymes used, CYP2B6 and CYP2C19 were the primary enzymes catalysing the metabolism of (‐)‐cis‐ and (‐)‐trans‐rose oxide. CYP1A2 also efficiently oxidized (‐)‐cis‐rose oxide at the 9‐position but not (‐)‐trans‐rose oxide. α‐Naphthoflavone (a selective CYP1A2 inhibitor), thioTEPA (a CYP2B6 inhibitor) and anti‐CYP2B6 antibody inhibited (‐)‐cis‐rose oxide 9‐hydroxylation catalysed by human liver microsomes. On the other hand, the metabolism of (‐)‐trans‐rose oxide was suppressed by thioTEPA and anti‐CYP2B6 at a significant level in human liver microsomes. However, omeprazole (a CYP2C19 inhibitor) had no significant effects on the metabolism of both isomers of rose oxide. Using microsomal preparations from nine different human liver samples, (‐)‐9‐hydroxy‐cis‐ and (‐)‐9‐hydroxy‐trans‐rose oxide formations correlated with (S)‐mephenytoin N‐demethylase activity (CYP2B6 marker activity). These results suggest that CYP2B6 plays important roles in the metabolism of (‐)‐cis‐ and (‐)‐trans‐rose oxide in human liver microsomes. Copyright © 2015 John Wiley & Sons, Ltd. 相似文献
55.
Hunter's observation in 1743 that cartilage "once destroyed, is not repaired" has not essentially changed for two and a half centuries. At present, there is no well-established procedure for the repair of cartilage defect with articular cartilage. Transplantation of human autologous chondrocytes in suspension, as reported by Brittberg et al., provided a potential procedure for articular cartilage repair. We have improved their procedure and developed a new technique, which creates new cartilage-like tissue by cultivating autologous chondrocytes embedded in atelocollagen gel for 3 weeks before transplantation. Good clinical results suggest that this technique should be a promising procedure for repairing articular cartilage defect. 相似文献
56.
57.
Sho Saito Kayoko Hayakawa Shinya Tsuzuki Masahiro Ishikane Maki Nagashima Kazuhisa Mezaki Yuko Sugiki Taichi Tajima Nobuaki Matsunaga Satoshi Ide Noriko Kinoshita Yoshiki Kusama Yumiko Fujitomo Takato Nakamoto Yuta Toda Mitsuo Kaku Eiichi N. Kodama Norio Ohmagari 《Antimicrobial agents and chemotherapy》2021,65(3)
58.
Kentaro Tokutomi Takashi Matsuura Phimon Atsawasuwan Hironobu Sato Mitsuo Yamauchi 《Connective tissue research》2013,54(5):361-366
At present, little is known about the age-related changes in jaw bones. The aim of this study was to characterize the mandibles of 6 month-old senile osteoporotic mice, SAMP6, and compare with those of age-matched controls, SAMR1. In comparison to SAMR1, SAMP6 showed thinner cortical bone, lower bone volume, and poorly organized collagen matrix. The collagen fibril diameter in SAMP6 was significantly smaller than that of SAMR1. In SAMP6 both collagen content and cross-links were lower than those of SAMR1, but the ratio of the major mature cross-link (pyridinoline) to its precursor reducible cross-link (dehydrodihydroxylysinonorleucine/its ketoamine) was higher in comparison to SAMR1. In addition, the extent of lysine hydroxylation of collagen was higher in SAMP6 than that of SAMR1. These results indicate that not only the quantity of collagen but also its quality are altered in SAMP6 and may result in the age-associated osteoporotic defects of mandibles. 相似文献
59.
Daisuke Kudo Kazuko Uno Tetsuji Aoyagi Yukiko Akahori Keiko Ishii Emi Kanno Ryoko Maruyama Shigeki Kushimoto Mitsuo Kaku Kazuyoshi Kawakami 《Inflammation》2013,36(4):812-820
Acute respiratory distress syndrome (ARDS) is accompanied by severe lung inflammation induced by various diseases. Despite the severity of symptoms, therapeutic strategies for this pathologic condition are still poorly developed. Interferon (IFN)-α is well known as an antiviral cytokine and low-dose IFN-α has been reported to show antiinflammatory effects. Therefore, we investigated how this cytokine affected ARDS in a mouse model. C57BL/6 mice received sequential intratracheal administration of α-galactosylceramide (α-GalCer) and lipopolysaccharide (LPS), which resulted in the development of fulminant ARDS. These mice were then treated intranasally with IFN-α and their survival, lung weight, pathological findings, and cytokine production were evaluated. Administration of low-dose IFN-α prolonged survival of fulminant ARDS mice, but higher doses of IFN-α did not. Histological analysis showed that low-dose IFN-α treatment improved findings of diffuse alveolar damage in fulminant ARDS mice, which was associated with reduction in the wet/dry (W/D) lung weight ratio. Furthermore, IFN-γ production in the lungs was significantly reduced in IFN-α-treated mice, compared with control mice, but tumor necrosis factor (TNF)-α production was almost equivalent for both groups. Low-dose IFN-α shows antiinflammatory and therapeutic effects in a mouse model of fulminant ARDS, and reduced production of IFN-γ in the lung may be involved in the beneficial effect of this treatment. 相似文献
60.